ICD-10-CM Billable Code

C44.119

Basal cell carcinoma of skin of left eyelid, including canthus

Clinical Classification Guidelines

Medical Intelligence & Overview

Basal cell carcinoma (BCC) is a common type of skin cancer that originates in the basal cells—a type of cell within the skin that produces new skin cells as old ones die. When this cancer develops on the skin of the left eyelid, including the canthus (the corner where the eyelids meet), it is classified under ICD-10 code C44.119. Usually slow-growing and locally invasive, BCC of the eyelid is a significant condition because of the proximity to the eye and essential structures involved in vision and eyelid function. Early diagnosis and treatment are crucial to prevent tissue destruction and preserve eye health.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds. Fair skin that is more susceptible to UV damage. History of frequent sunburns or excessive sun exposure over the years. Previous skin injuries or scars which may increase risk. Genetic factors, including conditions that predispose to skin cancers. Immunosuppression, which can impair the body’s ability to detect and destroy cancerous cells.

Key Symptoms: Small, translucent or pearly nodules on the eyelid, often with rolled edges. Presence of a waxy, wax-like appearance on the skin surface. Sometimes, ulceration or bleeding in the affected area. A persistent sore or sore that heals and then recurs. Scar-like areas that feel firm and may be slightly raised. Changes in skin color or texture around the eyelid.

Diagnostic & Treatment

Diagnosis Path: Diagnosis generally involves a physical examination of the eyelid and surrounding skin, focusing on visible lesions. A doctor may perform dermoscopy, a technique that allows closer inspection of skin structures. A definitive diagnosis requires a skin biopsy, where a small tissue sample from the lesion is taken and examined microscopically to confirm the presence of basal cell carcinoma. Imaging tests might be ordered to assess the extent of invasion if necessary, especially when deeper tissue involvement is suspected.

Treatment Protocols: Treatment options for BCC of the eyelid aim to remove the cancerous tissue while preserving eye function and appearance. Common approaches include: - Surgical excision: Cutting out the tumor with some surrounding healthy tissue. - Mohs micrographic surgery: A precise technique where cancerous tissue is removed layer by layer, examining each under a microscope until only cancer-free tissue remains. - Cryotherapy: Freezing the tumor with liquid nitrogen, typically used for superficial lesions. - Topical medications: Such as imiquimod or 5-fluorouracil, often used for superficial BCCs. - Radiation therapy: Employed when surgery is not feasible or as adjunct therapy. Post-treatment follow-up is essential to monitor for recurrence or new lesions, considering the risk factors involved.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C44.119 a billable ICD-10 code?
Yes, C44.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C44.119?
Clinical documentation must specify the nature of Basal cell carcinoma of skin of left eyelid, including canthus and any associated comorbidities for accurate reporting.

Cite this Clinical Reference